Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Jazz Pharmaceuticals
Bayer
Daiichi Sankyo
Tempus AI
Merck Sharp & Dohme LLC
Tongji Hospital
Elevation Oncology
pharmaand GmbH
Karolinska University Hospital
MultiVir, Inc.
National Institutes of Health Clinical Center (CC)
Cornerstone Pharmaceuticals
National Cancer Institute (NCI)
Royal Marsden NHS Foundation Trust
M.D. Anderson Cancer Center
Georgetown University